We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

maandag 24 juli 2017

Nature Reviews Rheumatology - Table of Contents alert Volume 13 Issue 8

If you are unable to see the message below, click here to view.

Nature Reviews Rheumatology

 
TABLE OF CONTENTS
 
August 2017 Volume 13 Number 8
Nature Reviews Rheumatology cover
2016 2-year Impact Factor 12.188 Journal Metrics 2-year Median 7
In this issue
Research Highlights
News and Views
Reviews
Perspectives

Also this month
 Featured article:
Synovial tissue research: a state-of-the-art review
Carl Orr, Elsa Sousa, David L. Boyle, Maya H. Buch, Christopher D. Buckley, Juan D. Cañete, Anca I. Catrina, Ernest H. S. Choy, Paul Emery, Ursula Fearon, Andrew Filer, Danielle Gerlag, Frances Humby, John D. Isaacs, Søren A. Just, Bernard R. Lauwerys, Benoit Le Goff, Antonio Manzo, Trudy McGarry, Iain B. McInnes, Aurélie Najm, Constantino Pitzalis, Arthur Pratt, Malcolm Smith, Paul P. Tak, Rogier Thurlings, João E. Fonseca & Douglas J. Veale
Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
RESEARCH HIGHLIGHTS Top

Systemic lupus erythematosus: IFN drives synapse loss via microglia
Published online: 06 July 2017
p449 | doi:10.1038/nrrheum.2017.109

PDF


Rheumatoid arthritis: Growing role for PADs in pathogenesis
Published online: 29 June 2017
p450 | doi:10.1038/nrrheum.2017.108

PDF


Spondyloarthropathies: MIF drives inflammation and bone formation in AS
Published online: 29 June 2017
p451 | doi:10.1038/nrrheum.2017.91

PDF


Lupus nephritis: NLRP3 inflammasome ignites podocyte dysfunction
Published online: 08 June 2017
p451 | doi:10.1038/nrrheum.2017.97

PDF


Immunology: Inhibiting autophagy in dendritic cells
Published online: 22 June 2017
p452 | doi:10.1038/nrrheum.2017.101

PDF


Stem cells: Synovial stem cells respond to a YAP
Published online: 08 June 2017
p452 | doi:10.1038/nrrheum.2017.93

PDF



IN BRIEF

Systemic lupus erythematosus: Tackling complexity through immunophenotyping | Rheumatoid arthritis: ACPA status influences RA development | Crystal arthritis: Combination therapy effective in tophaceous gout | Therapy: Rheumatic disease after immune checkpoint inhibitor therapy
PDF

Nature Reviews Rheumatology
JOBS of the week
Drug discovery project leaders
Servier
Post-doctoral Research Scholar - Immunology
University of California San Diego (UCSD)
More Science jobs from
Nature Reviews Rheumatology
EVENT
4th International Symposium on Intra-Articular Treatment
05.10.17
Prague, Czech Republic
More science events from
 
NEWS AND VIEWS Top
Systemic lupus erythematosus: The promise of PROMIS — is it ready for prime time in SLE?
Meenakshi Jolly & Patricia Katz
Published online: 22 June 2017
p453 | doi:10.1038/nrrheum.2017.100
Patient-reported outcomes are important predictors of morbidity and mortality. The validity and reliability of the Patient Reported Outcomes Measurement Information System (PROMIS) computerized adaptive tests (CATs) has been assessed in patients with systemic lupus erythematosus, but does PROMIS deliver on its promise?
Full Text | PDF
Systemic sclerosis: Choosing patients wisely when treating interstitial lung disease
Richard M. Silver
Published online: 06 July 2017
p455 | doi:10.1038/nrrheum.2017.103
Systemic sclerosis-associated interstitial lung disease (SSc-ILD) requires accurate diagnosis and staging to identify patients with the highest risk of disease progression, who might benefit from treatment with immunosuppressants. New insights into predictors of mortality in patients with SSc-ILD should improve patient care and inform the design of future clinical trials.
Full Text | PDF
Systemic lupus erythematosus: BAFF emerges from the genetic shadows
William Stohl
Published online: 15 June 2017
p456 | doi:10.1038/nrrheum.2017.99
A newly identified insertion-deletion variant of the B cell activating factor (BAFF)-encoding TNFSF13B gene leads to increased levels of soluble BAFF and is associated with the development of systemic lupus erythematosus. The discovery raises a number of compelling questions for further investigation.
Full Text | PDF
Rheumatoid arthritis: The benefits of early treatment after decades
Angela Zink & Katinka Albrecht
Published online: 29 June 2017
p458 | doi:10.1038/nrrheum.2017.104
Early, targeted treatment improves the outcome of rheumatoid arthritis, reducing disease-associated disability and mortality. Until now, it was unknown whether these beneficial effects extended beyond 10 years following initial therapy. Could these effects persist even after 20 years?
Full Text | PDF
Paediatric rheumatic disease: What is the best definition of clinical remission in JIA?
Gabriella Giancane & Angelo Ravelli
Published online: 29 June 2017
p460 | doi:10.1038/nrrheum.2017.105
The optimal definition of clinical remission in juvenile idiopathic arthritis is still uncertain. A new study has found that the current criteria for clinically inactive disease do not always identify the same group of patients. Why is there such a discrepancy? And which approach to defining remission is the most advantageous?
Full Text | PDF
 
REVIEWS Top
Synovial tissue research: a state-of-the-art review
Carl Orr, Elsa Sousa, David L. Boyle, Maya H. Buch, Christopher D. Buckley, Juan D. Cañete, Anca I. Catrina, Ernest H. S. Choy, Paul Emery, Ursula Fearon, Andrew Filer, Danielle Gerlag, Frances Humby, John D. Isaacs, Søren A. Just, Bernard R. Lauwerys, Benoit Le Goff, Antonio Manzo, Trudy McGarry, Iain B. McInnes, Aurélie Najm, Constantino Pitzalis, Arthur Pratt, Malcolm Smith, Paul P. Tak, Rogier Thurlings, João E. Fonseca & Douglas J. Veale
Published online: 13 July 2017
p463 | doi:10.1038/nrrheum.2017.115
Advances in synovial tissue research have improved our understanding of inflammatory arthritides, particularly rheumatoid arthritis, and have identified potential biomarkers that could be used for diagnosis, disease stratification, and predicting disease course and treatment response.
Abstract | Full Text | PDF
Visual loss and other cranial ischaemic complications in giant cell arteritis
Alessandra Soriano, Francesco Muratore, Nicolò Pipitone, Luigi Boiardi, Luca Cimino & Carlo Salvarani
Published online: 06 July 2017
p476 | doi:10.1038/nrrheum.2017.98
Visual loss is a major concern for patients with giant cell arteritis (GCA). In this Review, the authors discuss visual loss and other ischaemic events in GCA, its epidemiology, associated risk factors, clinical presentation and current therapeutic approaches.
Abstract | Full Text | PDF
Sexual and reproductive health in rheumatic disease
Monika Østensen
Published online: 06 July 2017
p485 | doi:10.1038/nrrheum.2017.102
Rheumatic diseases can affect sexual health, which can sometimes be overlooked by health professionals. In this Review, the author discusses the effect of rheumatic diseases and anti-rheumatic drugs on a patients' fertility and sexual functioning, and highlights how this knowledge should improve the managing and counselling of patients with rheumatic disease.
Abstract | Full Text | PDF
 
PERSPECTIVES Top
OPINION
Antinuclear antibody testing — misunderstood or misbegotten?
David S. Pisetsky
Published online: 25 May 2017
p495 | doi:10.1038/nrrheum.2017.74
The presence of antinuclear antibodies (ANAs) is an important criterion for the classification of autoimmune diseases such as systemic lupus erythematosus, but the specificity of ANA tests is controversial. This Perspectives article critically discusses the methods used in ANA testing for different diseases, as well as ways to improve the use of these assays in clinical and research settings.
Abstract | Full Text | PDF
OPINION
Biologics registers in RA: methodological aspects, current role and future applications
Elena Nikiphorou, Maya H. Buch & Kimme L. Hyrich
Published online: 01 June 2017
p503 | doi:10.1038/nrrheum.2017.81
The need to accurately assess the effectiveness of biologic therapies for rheumatoid arthritis in real-world settings has seen an explosion in nationwide biologics registers. In this Perspectives article, the authors discuss how to make the most of data from such registers.
Abstract | Full Text | PDF | Supplementary information
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events
Nature Reviews Rheumatology was previously published as Nature Clinical Practice Rheumatology.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our feedback department

Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature